CD274 and head and neck cancer: In adaptive immune resistance, the incoming immune response, including interferon-γ, makes the tumor resist further immune attack.28 TIC PD-L1 might suppress anti-tumor T-cell responses as seen in studies of total tumors1,21 and head and neck cancer TIC,9 yet TIC PD-L1 could render them more vulnerable to immune-mediated clearance.